Holen Sie sich die Stockscreener-App
103.60
0.31%
0.33
Exact Sciences Corp Aktie (EXAS) Neueste Nachrichten
Mackenzie Financial Corp Has $150.11 Million Stake in Exact Sciences Corporation $EXAS - MarketBeat
EXACT Sciences Corp. Hits New 52-Week High of $103.75 - Markets Mojo
Exact Sciences Case Study Links Higher Screening Rates With Undervalued Shares - Yahoo Finance
Exact Sciences stock hits 52-week high at 103.68 USD - Investing.com India
Exact Sciences EHR Outreach Program Highlights Cologuard Growth And Valuation Debate - simplywall.st
Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover - Stocktwits
A Look At Exact Sciences (EXAS) Valuation After Strong 1 Year Shareholder Returns - simplywall.st
CSLLY or EXAS: Which Is the Better Value Stock Right Now? - Yahoo! Finance Canada
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year - BioSpace
EXACT SCIENCES CORP (NASDAQ:EXAS) Shows Strong Technical and Fundamental Momentum - ChartMill
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration - BioSpace
Exact Sciences Stock: Is The Post-Earnings Slide A Buying Setup for 2026? - AD HOC NEWS
Exact Sciences (NASDAQ: EXAS) EVP exercises 3,900 options, 1,913 shares withheld - Stock Titan
Exact Sciences (EXAS) CEO reports RSU vesting and tax-withheld share dispositions - Stock Titan
KeyCare, Inc. announced that it has received $27.4 million in funding from a group of investors - marketscreener.com
Is Exact Sciences (EXAS) Pricing Reflect Long Term Cancer Screening Growth Potential - Yahoo Finance
Exact Sciences Corporation $EXAS Shares Sold by Fox Run Management L.L.C. - MarketBeat
EXAS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Pentwater Capital Management LP's Exact Sciences Corp(EXAS) Holding History - GuruFocus
[Form 4] EXACT SCIENCES CORP Insider Trading Activity - Stock Titan
EXACT Sciences (EXAS) HR EVP awarded 23,224 RSUs in new grant - Stock Titan
Exact Sciences (EXAS) grants SVP Herriott 20,321 restricted stock units - Stock Titan
EXACT Sciences (EXAS) CEO receives major RSU grant and tax-share withholding - Stock Titan
Exact Sciences (EXAS) awards 28,063 restricted stock units to EVP Baranick - Stock Titan
Exact Sciences (NASDAQ: EXAS) EVP receives 38,707 restricted stock units - Stock Titan
Exact Sciences (EXAS) Merger with Abbott Moving Forward After Shareholder Approval - Insider Monkey
December 18th Options Now Available For EXACT Sciences (EXAS) - Nasdaq
Market Outlook: Is Exact Sciences Corporation showing insider buyingJuly 2025 Selloffs & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Abbott Labs Increases Dividends for 54 Years, Acquires Exact Sciences - Intellectia AI
Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time - The Motley Fool
Abbott offers $20B in notes to finance Exact Sciences acquisition - MassDevice
Abbott Laboratories (ABT) sells $20B of notes to finance Exact Sciences acquisition - Stock Titan
Exact Sciences stock hits 52-week high at $103.55 By Investing.com - Investing.com India
Abbott Laboratories Kicks Off Bond Sale for Exact Sciences Deal - Bloomberg
Abbott lines up one of the year's biggest bond sales at $20B - Crain's Chicago Business
Abbott Laboratories Stock (ABT) Opinions on Exact Sciences Acquisition - Quiver Quantitative
Exact Sciences Stockholders Approve Abbott Merger as Executive Pay Proposal Fails at Special Meeting - Yahoo Finance
Exact Sciences (NASDAQ:EXAS) Hits New 52-Week HighTime to Buy? - MarketBeat
Abbott kicks off bond sale for Exact Sciences deal - Modern Healthcare
Exact Sciences stock hits 52-week high at $103.55 - Investing.com
Abbott Laboratories Commences 8-Part Bond Sale Tied to Exact Sciences Acquisition, Bloomberg Reports - marketscreener.com
Exact Sciences shareholders approve merger with Abbott Laboratories By Investing.com - Investing.com Nigeria
Exact Sciences (EXAS) Shareholders Approve Abbott Acquisition - GuruFocus
Exact Sciences shareholders approve merger with Abbott Laboratories - Investing.com
Exact Sciences stockholders approve acquisition by Abbott - marketscreener.com
Exact Sciences shareholders approve Abbott acquisition - Investing.com
Exact Sciences Shareholders Approve Acquisition by Abbott Laboratories - marketscreener.com
Exact Sciences shareholders approve $105 per share Abbott acquisition - StreetInsider
Exact Sciences Stockholders Approve Acquisition by Abbott - The Chronicle-Journal
Exact Sciences Corp.: The Quiet Cancer-Test Stock Everyone’s Watching - AD HOC NEWS
Exact Sciences Q4 Earnings Match Estimates, Revenues Beat, Stock Up - The Globe and Mail
Here's Why Exact Sciences (EXAS) is a Strong Momentum Stock - Yahoo Finance
Aberdeen Group plc Increases Stock Position in Exact Sciences Corporation $EXAS - MarketBeat
Exact Sciences Corporation $EXAS is Eagle Health Investments LP's 10th Largest Position - MarketBeat
Assessing Exact Sciences (EXAS) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
How The Abbott Offer Is Rewriting The Story For Exact Sciences (EXAS) - Yahoo Finance
How Investors May Respond To Exact Sciences (EXAS) Narrowing Losses And Oncotype DX Milestone - Yahoo Finance
0.76%
0.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):